BMC Cancer is an open access peer-reviewed journal that considers articles on all aspects of cancer research including the pathophysiology prevention diagnosis and treatment of cancers. The journal welcomes submissions concerning molecular and cellular
BMC Cancer does not consider case reports. For pre-clinical and experimental research we only consider studies that provide results validated in at least 3 relevant cell lines preferably validated in at least one animal model. Please note that manuscripts consisting solely of bioinformatics computational analysis or predictions of public
Cancer Metabolism is excited to present the following article highlights that identify novel biomarkers and metabolic profiles of different breast cancer subtypes.Metabolic profiling of triple-negative breast cancer cells reveals metabolic vulnerabilities ta-hydroxybutyrate (3-OHB) can influence the energetic phenotype of breast
BMC Cancer is an open access peer-reviewed journal that considers articles on all aspects of cancer research including the pathophysiology prevention diagnosis and treatment of cancers. The journal welcomes submissions concerning molecular and cellular
2020-6-24 · Colorectal cancer (CRC) continues to be a major public health problem both in the United States and worldwide it is the third most common cancer in the United States with approximately 150 000 new cases per year 1 2 . Metastatic disease currently remains predominantly incurable and treatment is primarily for palliation of symptoms and disease control.
A pioneer of open access publishing BMC has an evolving portfolio of high quality peer-reviewed journals including broad interest titles such as BMC Biology and BMC Medicine specialist journals such as Malaria Journal and Microbiome and the BMC Series. Expanding beyond biomedicine into the physical sciences mathematics and engineering disciplines BMC now offers a wider portfolio of
BMC Cancer is an open access peer-reviewed journal covering all aspects of cancer research including the pathophysiology of cancer prevention diagnosis and treatment.. has been in the process of posting for about 4 months and has experienced 3 revisions in the middle.
BMC Cancer is an open access peer-reviewed journal that considers articles on all aspects of cancer research including the pathophysiology prevention diagnosis and treatment of cancers. The journal welcomes submissions concerning molecular and cellular
2021-7-4 · BMC CANCER BMC CANCER 1471-2407 2021/JCR 4.430/Q3 ENGLAND Irregular 2001 889 OA Yes bmccancer.biomedcentral
BMC Pharmacology and Toxicology Transparent peer review BMC Research Notes Breast Cancer Research Cancer Metabolism Cancer Cell International Clinical Epigenetics Epigenetics Communications Fluids and Barriers of the CNS Genes Nutrition Genes and Environment Genome Medicine Hereditary Cancer in Clinical Practice Open peer review
2021-4-13 · Cancer Metabolism BMC Biology and Cancer Metabolism. Cross journal collection In the Light of Evolution . View all collections. On Biology . MinION Democratising biodiversity research by misusing a portable long-read sequencer for short-read barcoding. 04 December 2019.
Cancer is a group of diseases driven by inherently nanostructural problems. As such there are obvious benefits to treatments employing nanoscale structures and processes. Cancer Nanotechnology aims to provide a forum so that the most promising emerging themes should be pre-eminent in the minds of researchers working in one—or indeed both
2021-7-12 · BU-BMC Cancer Center Translating Scientific Findings into Clinical Results The BU-BMC Cancer Center provides high-quality patient care in combination with innovative research programs that directly transform cancer management through the discovery of personalized approaches for cancer detection and treatment.
Molecular Cancer is a top rated Springer Nature journal. Prof. Christophe Nicot and the editorial team performed in the top percentile of journals based on data collected from the Journal Author Satisfaction Survey. We are recognising extraordinary editors for their commitment and passion to their journals.
BMC Complementary Medicine and Therapies is an open access journal publishing original peer-reviewed research articles on interventions and resources that complement or replace conventional therapies with a specific emphasis on research that explores the biological mechanisms of action as well as their efficacy safety costs patterns of use
Radiation Oncology encompasses all aspects of research that impacts on the treatment of cancer using radiation. It publishes findings in molecular and cellular radiation biology radiation physics radiation technology and clinical oncology. The field of radiation oncology covers the integration of radiation therapy into multimodal treatment
Cancer cells have unique metabolic and bioenergetic properties allowing them to thrive in nutrient poor environments and maximize cell growth and proliferation. Myriad inputs feed into the metabolism of cancer and cancer-associated cells as well as interactions within the tumor microenvironment. Understanding the flexibility of changes in the
Cancer cells have unique metabolic and bioenergetic properties allowing them to thrive in nutrient poor environments and maximize cell growth and proliferation. Myriad inputs feed into the metabolism of cancer and cancer-associated cells as well as interactions within the tumor microenvironment. Understanding the flexibility of changes in the
BMC Medicine is the flagship medical journal of the BMC series. An open access transparent peer-reviewed general medical journal BMC Medicine publishes outstanding and influential research in all areas of clinical practice translational medicine medical and health advances public health global health policy and general topics of interest to the biomedical and sociomedical professional
Journal of Experimental Clinical Cancer Research is a top rated Springer Nature journal. Prof. Mauro Castelli and the editorial team performed in the top percentile of journals based on data collected from the Journal Author Satisfaction Survey. We are recognising extraordinary editors for their commitment and passion to their journals.
BMC Cancer is an open access peer-reviewed journal covering all aspects of cancer research including the pathophysiology of cancer prevention diagnosis and treatment.. has been in the process of posting for about 4 months and has experienced 3 revisions in the middle.
Molecular Cancer is an open access peer-reviewed journal interested in attracting high-quality original research and reviews that present or highlight significant advances in all areas of cancer and related biomedical science.
1 day ago · Cutaneous squamous cell carcinoma (cSCC) often follows actinic keratosis (AK) and is the second most common skin cancer worldwide. To reduce metastasis risk it is important to diagnose and treat cSCC early. This study aimed to identify hub genes associated with cSCC and AK. This study used three datasets GSE45216 GSE98774 and GSE108008. We combined samples from the GSE45216
1 day ago · Cutaneous squamous cell carcinoma (cSCC) often follows actinic keratosis (AK) and is the second most common skin cancer worldwide. To reduce metastasis risk it is important to diagnose and treat cSCC early. This study aimed to identify hub genes associated with cSCC and AK. This study used three datasets GSE45216 GSE98774 and GSE108008. We combined samples from the GSE45216
Cancer Cell International Celebrating 20 years. 2021 marks the 20th year since Cancer Cell International published its very first articles.To mark this occasion we re looking back at the journal s milestone achievements and highlighting some of the best content from the past 20 years.
1 day ago · Cutaneous squamous cell carcinoma (cSCC) often follows actinic keratosis (AK) and is the second most common skin cancer worldwide. To reduce metastasis risk it is important to diagnose and treat cSCC early. This study aimed to identify hub genes associated with cSCC and AK. This study used three datasets GSE45216 GSE98774 and GSE108008. We combined samples from the GSE45216
BMC Medicine is the flagship medical journal of the BMC series. An open access transparent peer-reviewed general medical journal BMC Medicine publishes outstanding and influential research in all areas of clinical practice translational medicine medical and health advances public health global health policy and general topics of interest to the biomedical and sociomedical professional
A pioneer of open access publishing BMC has an evolving portfolio of high quality peer-reviewed journals including broad interest titles such as BMC Biology and BMC Medicine specialist journals such as Malaria Journal and Microbiome and the BMC Series. Expanding beyond biomedicine into the physical sciences mathematics and engineering disciplines BMC now offers a wider portfolio of
Cancer Communications is no longer published by BMC. The journal is continuing in cooperation with Wiley as of 1 January 2020. The new journal website is
Cancer Cell International Celebrating 20 years. 2021 marks the 20th year since Cancer Cell International published its very first articles.To mark this occasion we re looking back at the journal s milestone achievements and highlighting some of the best content from the past 20 years.
Before you submit. Now you ve identified a journal to submit to there are a few things you should be familiar with before you submit. Make sure you are submitting to the most suitable journalAims and scope. Understand the costs and funding optionsFees and funding. Make sure your manuscript is accurate and readableLanguage editing
BMC Cancer Citations 15 227 BMC Cancer publishes original research articles in all aspects of research relating to cancer including molecular biology genetics pathophysiology epidemiology
BMC Complementary Medicine and Therapies is an open access journal publishing original peer-reviewed research articles on interventions and resources that complement or replace conventional therapies with a specific emphasis on research that explores the biological mechanisms of action as well as their efficacy safety costs patterns of use
BMC Medicine and BMC Cancer are welcoming submissions to a new joint collection on cancer targeted therapies. We are seeking manuscripts on all aspects of molecular targeted therapies including novel therapies treatment resistance combination therapies and biomarker discovery.
Cancer Metabolism is excited to present the following article highlights that identify novel biomarkers and metabolic profiles of different breast cancer subtypes.Metabolic profiling of triple-negative breast cancer cells reveals metabolic vulnerabilities ta-hydroxybutyrate (3-OHB) can influence the energetic phenotype of breast
BMC Complementary Medicine and Therapies is an open access journal publishing original peer-reviewed research articles on interventions and resources that complement or replace conventional therapies with a specific emphasis on research that explores the biological mechanisms of action as well as their efficacy safety costs patterns of use
At BMC research is always in progress. We are committed to continual innovation to better support the needs of our communities ensuring the integrity of the research we publish and championing the benefits of open research. BMC is part of Springer Nature.
Cancer Communications is no longer published by BMC. The journal is continuing in cooperation with Wiley as of 1 January 2020. The new journal website is
Molecular Cancer is a top rated Springer Nature journal. Prof. Christophe Nicot and the editorial team performed in the top percentile of journals based on data collected from the Journal Author Satisfaction Survey. We are recognising extraordinary editors for their commitment and passion to their journals.
BMC Cancer is an open access peer-reviewed journal covering all aspects of cancer research including the pathophysiology of cancer prevention diagnosis and treatment.. has been in the process of posting for about 4 months and has experienced 3 revisions in the middle.
BQ+ Medical not only produce components for manufacturers all over the world, but also provide private label manufacturing for leading brand distributors in different countries.
8,Cheye Road,Songjiang District,Shanghai 201611 China.
Tel: 86-021-57743953
Email: [email protected]
Copyright © BQ PLUS MEDICAL CO., LTDSitemap | Contact Us |
